Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nath

Showing results (101-110 of 535) with videos related to

Pageof 54
Sort By:
Journal of the American Society of Nephrology : JASN|January 26, 2020
Renal Functional Decline in Sickle Cell Disease and TraitKarl A Nath, Gregory M Vercellotti
Kidney International|December 1, 1990
Dietary deficiency of antioxidants exacerbates ischemic injury in the rat kidneyK A Nath, M S Paller
Mayo Clinic Proceedings|June 6, 2020
Introduction to Thematic Reviews on Aging and Geriatric MedicineRobert J Pignolo, Karl A Nath
Journal of Pharmaceutical Sciences|March 1, 1995
Compartment model to describe peripheral arterial-venous drug concentration gradients with drug elimination from the venous sampling compartmentJ R Jacobs, P A Nath
Biochimica Et Biophysica Acta|February 13, 1978
Emission Mössbauer studies of some organocobalaminsS Tyagi, K Inoue, A Nath
Mayo Clinic Proceedings|February 4, 2018
Disease Progression and End-Stage Renal Disease in Diverse GlomerulopathiesKarl A Nath, Fernando C Fervenza
Mayo Clinic Proceedings|December 8, 2018
Current, Emerging, and Anticipated Therapies for Sickle Cell DiseaseKarl A Nath, S Vincent Rajkumar
Mayo Clinic Proceedings|April 5, 2023
The Career of the Clinical Investigator: Quo Vadis?Karl A Nath, Vesna D Garovic
Hepatology (Baltimore, Md.)|July 1, 1997
Mechanism of the impairment of the glucagon-stimulated phosphoenolpyruvate carboxykinase gene expression by interleukin-6 in rat hepatocytes: inhibition of the increase in cyclic 3',5' adenosine monophosphate and the downstream cyclic 3',5' adenosine monophosphate actionB Christ, A Nath, K Jungermann
Journal of the American Society of Nephrology : JASN|April 27, 2017
Endothelin-A Receptor Antagonism Retards the Progression of Murine Sickle Cell NephropathyKarl A Nath, Zvonimir S Katusic
Pageof 54

Showing results (101-110 of 535) with videos related to

Sort By:
Pageof 54
Journal of the American Society of Nephrology : JASN|January 26, 2020
Renal Functional Decline in Sickle Cell Disease and TraitKarl A Nath, Gregory M Vercellotti
Kidney International|December 1, 1990
Dietary deficiency of antioxidants exacerbates ischemic injury in the rat kidneyK A Nath, M S Paller
Mayo Clinic Proceedings|June 6, 2020
Introduction to Thematic Reviews on Aging and Geriatric MedicineRobert J Pignolo, Karl A Nath
Journal of Pharmaceutical Sciences|March 1, 1995
Compartment model to describe peripheral arterial-venous drug concentration gradients with drug elimination from the venous sampling compartmentJ R Jacobs, P A Nath
Biochimica Et Biophysica Acta|February 13, 1978
Emission Mössbauer studies of some organocobalaminsS Tyagi, K Inoue, A Nath
Mayo Clinic Proceedings|February 4, 2018
Disease Progression and End-Stage Renal Disease in Diverse GlomerulopathiesKarl A Nath, Fernando C Fervenza
Mayo Clinic Proceedings|December 8, 2018
Current, Emerging, and Anticipated Therapies for Sickle Cell DiseaseKarl A Nath, S Vincent Rajkumar
Mayo Clinic Proceedings|April 5, 2023
The Career of the Clinical Investigator: Quo Vadis?Karl A Nath, Vesna D Garovic
Hepatology (Baltimore, Md.)|July 1, 1997
Mechanism of the impairment of the glucagon-stimulated phosphoenolpyruvate carboxykinase gene expression by interleukin-6 in rat hepatocytes: inhibition of the increase in cyclic 3',5' adenosine monophosphate and the downstream cyclic 3',5' adenosine monophosphate actionB Christ, A Nath, K Jungermann
Journal of the American Society of Nephrology : JASN|April 27, 2017
Endothelin-A Receptor Antagonism Retards the Progression of Murine Sickle Cell NephropathyKarl A Nath, Zvonimir S Katusic
Pageof 54